Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology

Published:2018-03 Issue:3 Volume:51 Page:493-497
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Bousquet Aurore,Bugier Sarah,Larréché Sébastien,Bigaillon Christine,Weber Philippe,Delacour Hervé,Valade Eric,De Briel Dominique,Mérens Audrey

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference21 articles.

1. Pivmecillinam in the treatment of urinary tract infections;Nicolle;J Antimicrob Chemother,2000

2. Amdinocillin;Farrar;Ann Intern Med,1984

3. High-level resistance to mecillinam produced by inactivation of soluble lytic transglycosylase in Salmonella enterica serovar Typhimurium;Costa;FEMS Microbiol Lett,2006

4. Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria;Dewar;J Antimicrob Chemother,2014

5. Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin;Giske;Clin Microbiol Infect,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Flavonoid and Chalcone Scaffolds as Leads for Synthetic Antitubercular Agents;Flavonoids and Phenolics;2022-12-01

2. Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption;Journal of Antimicrobial Chemotherapy;2022-11-28

3. Microbial risk factors for treatment failure of pivmecillinam in community‐acquired urinary tract infections caused by ESBL‐producing Escherichia coli;APMIS;2020-01-03

4. Polymorphism of Type I–F CRISPR/Cas system in Escherichia coli of phylogenetic group B2 and its application in genotyping;Infection, Genetics and Evolution;2019-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3